UnlockMithra postpones its annual general meeting
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Mithra Pharmaceuticals Sa (MITRA)
Brussels
Currency in EUR
Disclaimer
0.22
0.00(0.00%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.22
0.22
52 wk Range
0.20
1.51
MITRA Scorecard
Full Analysis
Operates with a significant debt burden
"Mithra Pharmaceuticals Sa stock price live, this page displays EBR MITRA stock exchange data. View the MITRA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Mithra Pharmaceuticals Sa real time stock price chart below.
What Is the Mithra Pharmaceuticals Sa Stock Price Today?
The Mithra Pharmaceuticals Sa stock price today is 0.22.
What Is the Stock Symbol for Mithra Pharmaceuticals Sa?
The stock symbol for Mithra Pharmaceuticals Sa is ""MITRA.""
What Stock Exchange Does Mithra Pharmaceuticals Sa Trade On?
Mithra Pharmaceuticals Sa is listed and trades on the Brussels stock exchange.
Is Mithra Pharmaceuticals Sa a Good Stock to Buy?
Determining whether Mithra Pharmaceuticals Sa—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MITRA quote. (ISIN: BE0974283153)"
What Is the Mithra Pharmaceuticals Sa Stock Price Today?
The Mithra Pharmaceuticals Sa stock price today is 0.22.
What Is the Stock Symbol for Mithra Pharmaceuticals Sa?
The stock symbol for Mithra Pharmaceuticals Sa is ""MITRA.""
What Stock Exchange Does Mithra Pharmaceuticals Sa Trade On?
Mithra Pharmaceuticals Sa is listed and trades on the Brussels stock exchange.
Is Mithra Pharmaceuticals Sa a Good Stock to Buy?
Determining whether Mithra Pharmaceuticals Sa—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MITRA quote. (ISIN: BE0974283153)"
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.220.22
52 wk Range
0.201.51
MITRA Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Mithra Pharmaceuticals Sa Company Profile
Mithra Pharmaceuticals SA develops, manufactures, and markets complex therapeutics in the areas of contraception, menopause, and hormone-dependent cancers in Belgium, Europe and internationally. Its development candidates include Estelle, a combined oral contraceptive that has completed phase III clinical trial; Donesta, which is in phase III clinical trial for estetrol-based oral hormone treatment; and products for neuroprotection and wound healing. The company also develops Myring, a contraceptive vaginal ring releasing a combination of hormones; Tibelia, a tablet composed of tibolone and a synthetic steroid used for hormone therapy in menopause; and Zoreline, a biodegradable subcutaneous implant for use in prostate and breast cancers, and benign gynecological indications. In addition, it provides products in polymeric forms, implants, sterile injectable products, and hormonal tablets. The company was founded in 1999 and is headquartered in Liège, Belgium.
Compare MITRA to Peers and Sector
Metrics to compare | MITRA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMITRAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.1x | −5.5x | −0.6x | |
PEG Ratio | - | −0.10 | 0.00 | |
Price/Book | −0.1x | 0.8x | 2.6x | |
Price / LTM Sales | 0.4x | 4.3x | 3.2x | |
Upside (Analyst Target) | −54.5% | 53.0% | 48.4% | |
Fair Value Upside | Unlock | 9.8% | 6.8% | Unlock |
FAQ
What Is the Mithra Pharmaceuticals Sa (MITRA) Stock Price Today?
The Mithra Pharmaceuticals Sa stock price today is 0.22
What Stock Exchange Does Mithra Pharmaceuticals Sa Trade On?
Mithra Pharmaceuticals Sa is listed and trades on the Brussels stock exchange.
What Is the Stock Symbol for Mithra Pharmaceuticals Sa?
The stock symbol for Mithra Pharmaceuticals Sa is "MITRA."
What Is the Mithra Pharmaceuticals Sa Market Cap?
As of today, Mithra Pharmaceuticals Sa market cap is 15.20M.
What is Mithra Pharmaceuticals Sa Earnings Per Share?
The Mithra Pharmaceuticals Sa EPS is -1.43.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.